Takako Matsuda Selected Research

Chronic Hepatitis C

7/2006

Treatment effects and predictors of a 24-week course of interferon alpha-2b plus ribavirin combination therapy for patients with chronic hepatitis C.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Takako Matsuda Research Topics

Disease

1	Glioma (Gliomas) 11/2013
1	Neoplasm Metastasis (Metastasis) 01/2011
1	Neoplasms (Cancer) 01/2011
1	Experimental Melanoma 01/2011
1	Chronic Hepatitis C 07/2006
1	Pain (Aches) 07/2006
1	Osteoarthritis 03/2006
1	Rheumatoid Arthritis 03/2006

Drug/Important Bio-Agent (IBA)

1	Vitamin K 3 (Menadione)FDA Link 11/2013
1	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 11/2013
1	NAD (NADH)IBA 11/2013
1	NAD(P)H Dehydrogenase (Quinone) (Quinone Reductase)IBA 11/2013
1	Interleukin-12 (IL 12)IBA 01/2011
1	Amrinone (Amrinon)FDA Link 01/2011
1	Monoclonal AntibodiesIBA 01/2011
1	juzentaihotoIBA 01/2011
1	CytokinesIBA 01/2011
1	InterferonsIBA 07/2006
1	Dynorphins (Dynorphin)IBA 07/2006
1	Ribavirin (Virazole)FDA LinkGeneric 07/2006
1	Aligeron (AS 2)IBA 07/2006
1	Matrix Metalloproteinases (MMPs)IBA 03/2006
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 03/2006
1	Meloxicam (Mobic)FDA LinkGeneric 03/2006

Therapy/Procedure

2	Therapeutics 01/2011 - 07/2006
1	Intravenous Injections 01/2011
1	Oral Administration 01/2011
1	Kampo Medicine (Kampo) 01/2011
1	Intraperitoneal Injections 01/2011